These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27218785)

  • 1. Assessing Prognosis in Uveal Melanoma.
    Correa ZM
    Cancer Control; 2016 Apr; 23(2):93-8. PubMed ID: 27218785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in prognostic and predictive testing in uveal melanoma.
    Field MG; Harbour JW
    Curr Opin Ophthalmol; 2014 May; 25(3):234-9. PubMed ID: 24713608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uveal melanoma prognostication: from lesion size and cell type to molecular class.
    Gill HS; Char DH
    Can J Ophthalmol; 2012 Jun; 47(3):246-53. PubMed ID: 22687301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma - A Comprehensive Review.
    Berus T; Halon A; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P
    Anticancer Res; 2017 Dec; 37(12):6541-6549. PubMed ID: 29187428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular prognostic testing and individualized patient care in uveal melanoma.
    Harbour JW
    Am J Ophthalmol; 2009 Dec; 148(6):823-9.e1. PubMed ID: 19800609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MOLECULAR PROGNOSTICS FOR UVEAL MELANOMA.
    Seider MI; Mruthyunjaya P
    Retina; 2018 Feb; 38(2):211-219. PubMed ID: 28665870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of advanced genetic testing for clinical prognostication in uveal melanoma.
    Werdich XQ; Jakobiec FA; Singh AD; Kim IK
    Semin Ophthalmol; 2013; 28(5-6):361-71. PubMed ID: 24010756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-gene-based prognostic model predicts overall survival in patients with uveal melanoma.
    Wan Q; Tang J; Lu J; Jin L; Su Y; Wang S; Cheng Y; Liu Y; Li C; Wang Z
    Cancer Biomark; 2020; 27(3):343-356. PubMed ID: 31903983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Metastatic Uveal Melanoma: Progress and Challenges.
    Spagnolo F; Picasso V; Spano L; Tanda E; Venzano C; Queirolo P
    BioDrugs; 2016 Jun; 30(3):161-72. PubMed ID: 27000042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uveal Melanoma:
    Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
    Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
    Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
    Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of gene expression analysis in uveal melanoma in comparison to standard risk factors for risk assessment of subsequent metastases.
    Petrausch U; Martus P; Tönnies H; Bechrakis NE; Lenze D; Wansel S; Hummel M; Bornfeld N; Thiel E; Foerster MH; Keilholz U
    Eye (Lond); 2008 Aug; 22(8):997-1007. PubMed ID: 17384575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
    Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
    Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic prognostication in uveal melanoma.
    Dogrusöz M; Jager MJ
    Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of autotaxin predicts survival in uveal melanoma.
    Singh AD; Sisley K; Xu Y; Li J; Faber P; Plummer SJ; Mudhar HS; Rennie IG; Kessler PM; Casey G; Williams BG
    Br J Ophthalmol; 2007 Oct; 91(10):1385-92. PubMed ID: 17475713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of Bad Prognosis in Uveal Melanoma.
    Shao YF; Echegaray JJ; Singh N; Singh AD
    Ophthalmol Retina; 2019 Feb; 3(2):186-193. PubMed ID: 31014770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis.
    van Gils W; Lodder EM; Mensink HW; Kiliç E; Naus NC; Brüggenwirth HT; van Ijcken W; Paridaens D; Luyten GP; de Klein A
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4254-62. PubMed ID: 18552379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas.
    Field MG; Durante MA; Decatur CL; Tarlan B; Oelschlager KM; Stone JF; Kuznetsov J; Bowcock AM; Kurtenbach S; Harbour JW
    Oncotarget; 2016 Sep; 7(37):59209-59219. PubMed ID: 27486988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics.
    Plasseraud KM; Wilkinson JK; Oelschlager KM; Poteet TM; Cook RW; Stone JF; Monzon FA
    Diagn Pathol; 2017 Aug; 12(1):59. PubMed ID: 28778171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.